Medicilon Logo
search icon search icon language icon contact icon menu icon
Medicilon Logo
search icon close search icon language icon contact icon menu icon
logo icon CN
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Join Medicilon at BioTrinity 2022: Catalysing Growth in the Life Sciences Industry

Page View:


BioTrinity 2022 is only a couple weeks away! Medicilon is excited to attend and exhibit at the conference. Our Vice President and Business Development team will be exhibiting at the conferenceWe are happy to meet you in person to discuss how our services and capabilities would support your current research needs and expedite your drug discovery and development programs. We look forward to seeing you soon and wish you safe trips!

Date: April 26-27, 2022

Location: England, United Kingdom

ABOUT BioTrinity 2022

BioTrinity is an established, must-attend London conference, that catalyses growth and supports in-person re-engagement across the life sciences industry. The event is attended by an audience of early stage and emerging life sciences R&D Companies, investors, big pharma, and other valued partners throughout the life sciences ecosystem. The conference features a focused, relevant, and stimulating programme, led by great speakers, who bring their knowledge, expertise, and vision to the fore in exciting, high-quality sessions.

BioTrinity 2022 will feature

A dedicated 'Scientific Track', featuring a focus on seven core therapy areas; Oncology, CNS, Microbiome, Inflammation, Rare Disease, Infectious Diseases, as well as AI & Data.

A second 'life sciences business' focused presentation track, that will feature discussions and keynotes addressing topics from finance and investment, regulatory, government strategy and tax.

About Medicilon

Medicilon is an integrated contract research organization (CRO), providing comprehensive one-step new drug R&D for pharmaceutical enterprises and scientific research institutions around the world. We provide one-stop customized R&D solutions ranging from precise drug targeting to IND filing assistance.

Deeply integrate R&D experience, constantly climb the peak of R&D technology, and build an integrated innovation service platform for new drug R&D

Innovative Drug R&D Services

Antibody-Drug Conjugate(ADC) R&D project

PROTAC Drug Discovery Research Platform

mRNA Vaccine Bioanalysis Platform

Non-clinical Research for Cellular Immunotherapies

#drugdiscovery #BioTrinity #AI

Relevant newsRelevant news